Sinocare's All-Scenario Solutions Shine at the 91st CMEF: Digital Transformation Reshapes the Entire Diabetes Management Chain

From April 8 to 11, 2025, the 91st China International Medical Equipment (Spring) Expo (CMEF) grandly opened at the National Exhibition and Convention Center in Shanghai. As a global innovation benchmark for the medical industry, CMEF attracted elites, corporate representatives, and professionals from around the world, coming together to witness cutting-edge technologies and innovative products in the field of medical devices.

Sinocare, with the theme of "The Leading Diabetes Digital Management Expert in the World," made a significant appearance, showcasing four key areas and core technological achievements: the PPL (Personal Palm Lab), PDL (Precision Desk Lab), PWS(Precision Wearable Systems), Digital Diabetes Management Solution. Through its all-scenario technology matrix, Sinocare demonstrated its innovation strength and industry leadership in the field of diabetes management.

Sinocare's Theme Booth at the 2025 Spring CMEF

Technological Innovation Breakthrough: Sinocare iCan Sets New Industry Benchmark

The Precision Wearable System area integrates leading biosensing technology with AI algorithms, providing health monitoring, exercise management, and personalized intervention solutions to achieve precise and dynamic health management services. Among them, Sinocare’s latest CGM product, the Sinocare iCan CGM 2nd Generation, became the focus of the event due to its revolutionary innovation. This product boasts three core advantages: "simple to wear, lightweight and compact, accurate and stable," covering clinical, retail, and international channels, and has gained recognition from experts and customers both domestically and internationally.

Exhibitors Consulting the Sinocare iCan at the Sinocare Booth

Notably, the CE-MDR certification is the "gold standard" for EU medical device entry, with strict requirements on product design, manufacturing, and clinical data. Sinocare iCan is the first domestic CGM brand to pass this certification, marking that Sinocare's technological system has fully aligned with international top-level standards.

According to the latest "Global Diabetes Map" (11th edition) published by the International Diabetes Federation (IDF), nearly one in nine adults globally (589 million) lives under the shadow of diabetes, with about 252 million unaware of their condition, putting them at a higher risk of severe complications and early death.

Exhibitors Trying on the Sinocare iCan

Since 2023, Sinocare has continuously organized free trial and science popularization activities for CGM at CMEF, aiming to enhance public awareness and attention to diabetes, promoting the concept of early detection and intervention. Through these activities, many users have had the opportunity to experience the outstanding performance of the Sinocare iCan CGM 2nd Generation firsthand, gaining a deeper understanding of the importance of continuous glucose monitoring in diabetes management and experiencing the paradigm shift in health management brought about by technological innovation.

In addition to the new CGM products, Sinocare also presented its popular "Personal Palm Lab," which offers multi-parameter testing services covering blood glucose, blood lipids, uric acid, glycated hemoglobin, blood pressure, and more. This lab is capable of connecting to the internet and seamlessly transmitting data, creating value around Sinocare’s users and families by enabling data interoperability across hospitals, primary healthcare settings, and home environments.

Sinocare’s Rich Series of Chronic Disease Multi-Indicator Testing Products

Integrating Digital Technology with Health Management to Empower Precision Diagnosis and Treatment

In both primary healthcare and hospital management fields, Sinocare has demonstrated a comprehensive technical layout, utilizing innovation to support the improvement of the hierarchical diagnosis and treatment system. The iCARE-1300, a portable, fully automated multi-functional testing device aimed at primary healthcare settings, attracted industry attention. This device innovatively integrates three testing modules: five-part blood routine, liquid-phase biochemistry, and fluorescence immunoassay, providing primary healthcare institutions with a cost-effective solution to create a "one machine with multiple functions, one table for testing" intelligent testing scenario.

Sinocare Diabetes Digital Management Solution

For hospitals, Sinocare's inpatient blood glucose management proactive consultation system relies on its digital diabetes management platform, helping hospitals standardize the management of diabetes patients both inside and outside the hospital. By using information and digital tools, it enhances the efficiency of blood glucose testing and data management for healthcare professionals, proactively conducts consultations for critical value alerts, and manages abnormal blood glucose levels across departments. This digital-driven approach helps build the hospital's professional capabilities.

Sinocare actively leverages its strengths, continuously increasing investments in information technology and expanding collaborations with hospitals of all levels, including primary healthcare institutions, to promote the development of medical alliances and build regional chronic disease management platforms to improve comprehensive chronic disease prevention and treatment at the regional level. Meanwhile, leveraging information technology, it ensures interoperability among medical institutions and between hospitals and home settings, creating an integrated chronic disease management solution that spans hierarchical diagnosis and treatment.

Sinocare iCARE Series Products Receive Attention

The Sinocare Minute Clinic’s one-stop multi-parameter chronic disease testing also attracted numerous visitors to experience it at the exhibition. This service relies on Sinocare’s strong product development capabilities and professional medical service teams to quickly complete tests for multiple chronic disease indicators, such as blood glucose, blood lipids, uric acid, and blood pressure, in a short period. It provides personalized health reports and management recommendations, pushing the development of chronic disease management toward community-based, home-based, and intelligent directions.

Many Visitors Experience the Sinocare Minute Clinic

From technological innovation to ecosystem construction, from empowering primary healthcare to global expansion, from cross-sector cooperation to global layout, Sinocare is redefining the entire diabetes management chain with technological innovation and ecosystem collaboration at its core.